Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Comparative study of different sources of pertussis toxin (PT) as coating antigens in IgG anti-PT enzyme-linked immunosorbent assays.

Kapasi A, Meade BD, Plikaytis B, Pawloski L, Martin MD, Yoder S, Rock MT, Coddens S, Haezebroeck V, Fievet-Groyne F, Bixler G, Jones C, Hildreth S, Edwards KM, Messonnier NE, Tondella ML.

Clin Vaccine Immunol. 2012 Jan;19(1):64-72. doi: 10.1128/CVI.05460-11. Epub 2011 Nov 23.

2.

Comparison of Western immunobloting to an enzyme-linked immunosorbent assay for the determination of anti-Bordetella pertussis antibodies.

Merrigan SD, Welch RJ, Litwin CM.

Clin Vaccine Immunol. 2011 Apr;18(4):615-20. doi: 10.1128/CVI.00450-10. Epub 2011 Feb 9.

3.

Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative study.

Xing D, Wirsing von König CH, Newland P, Riffelmann M, Meade BD, Corbel M, Gaines-Das R.

Clin Vaccine Immunol. 2009 Mar;16(3):303-11. doi: 10.1128/CVI.00372-08. Epub 2008 Dec 24.

4.

EUVAC.NET collaborative study: evaluation and standardisation of serology for diagnosis of pertussis.

Xing D, Markey K, Newland P, Rigsby P, Hockley J, He Q.

J Immunol Methods. 2011 Sep 30;372(1-2):137-45. doi: 10.1016/j.jim.2011.07.005. Epub 2011 Jul 18.

PMID:
21782823
5.

Prospective evaluation of an Australian pertussis toxin IgG and IgA enzyme immunoassay.

May ML, Doi SA, King D, Evans J, Robson JM.

Clin Vaccine Immunol. 2012 Feb;19(2):190-7. doi: 10.1128/CVI.05430-11. Epub 2011 Nov 30.

6.

Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis.

Riffelmann M, Thiel K, Schmetz J, Wirsing von Koenig CH.

J Clin Microbiol. 2010 Dec;48(12):4459-63. doi: 10.1128/JCM.01371-10. Epub 2010 Oct 13.

7.

Evaluation of a tetraplex microsphere assay for Bordetella pertussis antibodies.

Prince HE, Lapé-Nixon M, Matud J.

Clin Vaccine Immunol. 2006 Feb;13(2):266-70.

8.

Pertussis serology: assessment of IgG anti-PT ELISA for replacement of the CHO cell assay.

Dalby T, Sørensen C, Petersen JW, Krogfelt KA.

APMIS. 2010 Dec;118(12):968-72. doi: 10.1111/j.1600-0463.2010.02664.x. Epub 2010 Sep 2.

10.

Development and validation of an Australian in-house anti-pertussis toxin IgG and IgA enzyme immunoassay.

May ML, Evans J, Riley J, Lambkin G, Robson JM.

Pathology. 2013 Feb;45(2):172-80. doi: 10.1097/PAT.0b013e32835c76e2.

PMID:
23250035
11.

Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis.

de Melker HE, Versteegh FG, Conyn-Van Spaendonck MA, Elvers LH, Berbers GA, van Der Zee A, Schellekens JF.

J Clin Microbiol. 2000 Feb;38(2):800-6.

13.

Development and analytical validation of an immunoassay for quantifying serum anti-pertussis toxin antibodies resulting from Bordetella pertussis infection.

Menzies SL, Kadwad V, Pawloski LC, Lin TL, Baughman AL, Martin M, Tondella ML, Meade BD; Pertussis Assay Working Group.

Clin Vaccine Immunol. 2009 Dec;16(12):1781-8. doi: 10.1128/CVI.00248-09. Epub 2009 Oct 28.

14.

Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.

Salmaso S, Mastrantonio P, Tozzi AE, Stefanelli P, Anemona A, Ciofi degli Atti ML, Giammanco A; Stage III Working Group.

Pediatrics. 2001 Nov;108(5):E81.

PMID:
11694665
15.

Response and decline of serum IgG antibodies to pertussis toxin, filamentous hemagglutinin and pertactin in children with pertussis.

Isacson J, Trollfors B, Hedvall G, Taranger J, Zackrisson G.

Scand J Infect Dis. 1995;27(3):273-7.

PMID:
8539553
16.

Comparison of five commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis.

Kösters K, Riffelmann M, Dohrn B, von König CH.

Clin Diagn Lab Immunol. 2000 May;7(3):422-6.

17.

[Detection of Bordetella pertussis infection by culture, real-time polymerase chain reaction and serologic tests among children with prolonged cough].

Gürsel D, Aslan A, Sönmez C, Koturoğlu G, Cöplü N, Kurugöl Z, Aydemir S.

Mikrobiyol Bul. 2012 Apr;46(2):211-24. Turkish.

PMID:
22639310
18.

Relationships between functional assays and enzyme immunoassays as measurements of responses to acellular and whole-cell pertussis vaccines.

Meade BD, Lynn F, Reed GF, Mink CM, Romani TA, Deforest A, Deloria MA.

Pediatrics. 1995 Sep;96(3 Pt 2):595-600. Erratum in: Pediatrics 1995 Dec;96(6):following 1199.

PMID:
7659484
19.

Antibody response patterns to Bordetella pertussis antigens in vaccinated (primed) and unvaccinated (unprimed) young children with pertussis.

Cherry JD, Heininger U, Richards DM, Storsaeter J, Gustafsson L, Ljungman M, Hallander HO.

Clin Vaccine Immunol. 2010 May;17(5):741-7. doi: 10.1128/CVI.00469-09. Epub 2010 Mar 24.

20.

Opsonophagocytic activity and other serological indications of Bordetella pertussis infection in military recruits in Norway.

Aase A, Herstad TK, Merino S, Brandsdal KT, Berdal BP, Aleksandersen EM, Aaberge IS.

Clin Vaccine Immunol. 2007 Jul;14(7):855-62. Epub 2007 May 16.

Supplemental Content

Support Center